Investment Q&A

Q: I recently heard of the $BPENER as a marker for oil sentiment. It is carried by Stock Charts here: https://stockcharts.com/sc3/ui/?s=%24BPENER
Are you familiar with this? Can you explain it to me as much as you know? How it works? And how to best way you can use it? Or best not at all?

Q: I’m looking at buying into one of ATRL, STN or WSP. I am struck by the low PE of ATRL vs the other 2 (5.6, 30.9 and 36.7 respectively).
I understand this is due to higher earnings this year from ATRL. Is this likely to continue or is it an anomaly?
Which would you buy today for a long-term hold?

Q: Jim Chanos has expressed the opinion that NBIS and CRWV are capital intensive, low margin, and high risk investments. Your comments much appreciated. Thanks.

Q: I’m doing a fairly major portfolio clean-up and account optimization exercise.
Specifically, I’m removing dividend-oriented and income-generating stocks from my TFSA and RRSP that are better suited to a non-registered account, and reallocating TFSA/RRSP capital to assets that benefit most from tax sheltering.

At a broad level, I’d appreciate your perspective on:

• Which CAD and USD names are best suited to an RRSP (e.g., U.S. dividend payers, global compounders, cyclicals, etc.)
• Which CAD and USD names are best suited to a TFSA (long-term growth, compounding, low income leakage)

I’m less interested in yield optimization and more focused on long-term after-tax efficiency and proper account placement.

If helpful, feel free to answer at a category level (e.g., “U.S. dividend aristocrats,” “Canadian compounders,” etc.) or with specific examples you think are particularly well-suited.

Thanks — looking forward to your thoughts.

Q: Can you comment on Saturns announced 2026 capital plan and forecast. At what point do you like its debt ratio to be attractive.

Q: I would appreciate several recommendations for platinum and palladium producing companies in order of priority considering relatively safe jurisdictions and potential price appreciation.
Thank you,
Ed

Q: Hello Team,

Considering the facts that:
Lumentum (LITE) is the High-Alpha play. It has the most momentum and the most critical technology (OCS), but it is currently considered "high risk/high reward" due to its vertical price chart.

Coherent (COHR) is the Catch-up play. It is favored by analysts who see "underappreciated upside." If Coherent can prove it is winning a larger share of the 1.6T transceiver market in its next earnings call (early 2026), its stock could "gap up" to match Lumentum's valuation.

For a 10 year investment, would you prioritize one over another? Or would you buy both?

Thank you for help all of us become richer and more informed in 2025. I wish you all at 5i a merry holiday season and a happy 2026. :)

Q: Lots of talk lately about the MJ sector given Trump's recent announcements. It has been almost 3 years since you spoke about HITI so would appreciate an update.

By all means, wait until January for this and have a great holiday.

Q: Will the webinar featuring Ryan's 2026 outlook from Dec 16th be made available?

Unfortunately, I missed the recording and I would very much like to view it. Thx and happy holidays!

Q: We are looking to inject more growth into our TFSAs - can accept reasonable degree of risk. Looking for concentrated list 10 stocks for 3-5 year hold.

Q: Hi Gang

Thanks for your great service

What are Your top Gold. Copper and Sliver ETFs at this time
Thanks MIke B

Q: Hi Peter and 5i,
Like the momentum of both companies. Like the strong net cash position of TIH.
Which one would you pick of the 2 for the potential highest return over the next 5 years?
Is it FTT based on 5i starting a new position in your Balanced Portfolio? Or is it a coin toss?

Q: ZOMD Can I get a quick explanation on what they do ? I know it was a recent recommendation, would you still recommend it after the decline ?

Q: What do you think of this small company with a nice dividend? Would love your thoughts on the viability of the dividend and any growth forward with the stock price?
Thanks as usual
Gary

Q: your opinion on FOM, also will they need to raise more money

Q: Order Fill Limit Order Tips for ETFs. I have been placing limit orders to buy TCSH ETF which is a Canadian money market ETF. I have access to Time & Sales data using TD Advanced Dashboard. It looks like the transaction prices vary between 50.10 and 50.11 with "size" typically 100 to 200. I am not sure if "size" refers to lot size or quantity of shares (maybe you guys know?). I would like to buy 1,800 shares at 50.10. Will I have better success rate if I place multiple limit orders using lower quantities at 50.10 or likely the same result if I just place 1 limit order for 1,800 shares at 50.10? Your thoughts would be appreciated.

Q: My portfolio by region is Canada 58%, US 37%, International 5%. It is recommended that I put my international to 25%. What are 5 stocks/ETF's that you would recommend that would increase my international exposure? Industry-wise, I am heavy on financials and energy already, and I prefer a balanced portfolio. Thanks!

Q: in regards to nicks question on Tesla,I have been driving with Full Self Drive for the last year and the improvement with Grok and Ai added in the last updates have made it incredible, most drives in and around town take no interventions from me, FSD is almost there and only 8% of Tesla drivers have it now, at 99$ per month it could be a sizeable contribution to cash flow,

Q: Trying to decide whether to keep SIS or look for something with a greater return potential. When I look at the profile, (evening Dec 18), I see that it is trading at a P/E of 25.31 which seems to be based on earnings of .86, which is very close to mathing out at the share price shown of $22.25.
I also see that the current consensus estimate for EPS in 2026 is 1.37. If SIS trades at a similar P/E in Dec 2026, as it is now, 25.31, then that would give a potential share price of $34.67, approximately 56% above the current price. I see that target prices are $26-$30. Even at $30, that would make the P/E in Dec 2026 about 21; below where it is now. So, is SIS over valued now or are the estimates too low and this should be kept or bought? The high and low P/E shown in the data are very far apart so not really applicable.

An interesting note to add is that I asked Google AI for the P/E in the last 5 years and it shows the following for Dec of each of the years shown:
2020-27.4
2021-102.7 Covid outlier I guess
2022-25.5
2023-26.2
2024-29.1
2025-25.4

Sorry for the length here but don't know how else to explain my predicament...

Was going to make this public but didn't because of length- feel free to change the status if you wish.

Q: Greetings 5i, I am looking closely at Stryker to increase Healthcare exposure. Please provide your analysis of this company in terms of stability, valuation and future growth prospects. What makes it stand out from its peers? Thank you.